COA Available
Nootropic In Stock Research Use Only
Selank
5mg · Lyophilized Powder · Purity ≥99%
Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin, studied in neuropsychopharmacology research for its effects on GABAergic signalling, neurotransmitter gene expression, and anxiety-related pathways in preclinical models.
$49.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Selank (TKPRPGP) has been characterized as a research tool in GABAergic system studies, demonstrating allosteric modulator-like spectral activity in preclinical paradigms without evidence of direct GABA receptor binding — a profile that distinguishes it from classical benzodiazepines. Preclinical research has documented its influence on the expression of genes governing serotonergic, dopaminergic, and GABAergic neurotransmission, as well as inhibition of enkephalin-degrading enzymes. Its immune-modulatory properties — inherited in part from the tuftsin backbone — have been an additional area of preclinical investigation. Supplied exclusively for laboratory and research use.
In neuropsychopharmacology research models, Selank has been studied for allosteric modulation of GABA receptor activity, producing anxiolytic-like spectral changes in preclinical behavioural paradigms comparable to benzodiazepine reference compounds without direct GABA binding. Gene expression studies have shown modulation of serotonin transporter, dopamine receptor, and GABAergic pathway transcripts in relevant cell and animal models. Selank has further been investigated for its capacity to inhibit enkephalin-degrading peptidases, extending the duration of endogenous opioid signalling in research systems. All outcomes referenced pertain to preclinical models and do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | Selank |
| Format | Lyophilized Powder |
| Size | 5mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-SELANK-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $49.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-SELANK-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Selank lyophilized powder should be stored at −20°C in a dry, sealed container, shielded from light and humidity to preserve peptide stability. Avoid repeated freeze-thaw cycles; prepare single-use aliquots before initial reconstitution. Reconstituted solutions should be stored at 4°C and used within intervals consistent with laboratory SOP guidelines.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 5mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
